Omnicell Inc. (OMCL) Stock Price, Quote & News

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Omnicell Inc. (OMCL)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

42.30

-0.02 (-0.05%)

At close: Jan 14, 2025, 3:59 PM

42.32

0.05%

After-hours Jan 14, 2025, 04:00 PM EST

undefined% (undefined)

Bid	41.27
Market Cap	1.96B
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	-0.39
PE Ratio (ttm)	-108.46
Forward PE	n/a
Analyst	Hold

Ask	47.69
Volume	179,877
Avg. Volume (20D)	578,939
Open	42.49
Previous Close	42.32
Day's Range	41.49 - 42.57
52-Week Range	25.12 - 55.75
Beta	undefined

About OMCL

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital,...

[Show more]

Industry Medical - Healthcare Information Services

Sector Healthcare

IPO Date Aug 9, 2001

Employees 3,660

Stock Exchange NASDAQ

Ticker Symbol OMCL

Website https://www.omnicell.com

Analyst Forecast

According to 6 analyst ratings, the average rating for OMCL stock is "Hold." The 12-month stock price forecast is $47, which is an increase of 11.11% from the latest price.

Buy 33.33%

Hold 66.67%

Sell 0.00%

Stock Forecasts

Next Earnings Release

Omnicell Inc. is scheduled to release its earnings on Feb 6, 2025, before market opens.
Analysts project revenue of $287.96M, reflecting a 11.25% YoY growth and earnings per share of 0.47, making a 42.42% increase YoY.

Why Price Moved

1 month ago · Source

+0.83%

Omnicell shares are trading lower after the compan... Unlock content with Pro Subscription

2 months ago · Source

+32.23%

Omnicell shares are trading higher after the company reported better-than-expected Q3 financial results and raised its FY24 guidance above estimates. Also, the company issued Q4 guidance above estimates.

News

1 day ago · businesswire.com

Omnicell to Release Fourth Quarter and Full Year 2024 Financial Results on February 6, 2025

FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell to Release Fourth Quarter and Full Year 2024 Financial Results on February 6, 2025.

6 days ago · businesswire.com

Omnicell to Present at the 43rd Annual J.P. Morgan Healthcare Conference

FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell to Present at the 43rd Annual J.P. Morgan Healthcare Conference.

1 week ago · zacks.com

Omnicell Gains 26.2% in a Year: What's Driving the Stock?

OMCL's shares rise on the back of its XT Amplify program gaining market traction with its initial offerings. However, the unfavorable macroeconomic scenario is concerning.

3 weeks ago · zacks.com

4 Healthcare Technology Innovators to Invest in Before the New Year

Here, we have presented four healthcare technology stocks for stable portfolio gains in 2025: VCYT, OMCL, MASI and ABT.

3 weeks ago · zacks.com

Why Omnicell (OMCL) Might be Well Poised for a Surge

Omnicell (OMCL) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

4 weeks ago · zacks.com

New Strong Buy Stocks for December 18th

LTM, OMCL, DXPE, ALL and CRS have been added to the Zacks Rank #1 (Strong Buy) List on December 18, 2024.

1 month ago · zacks.com

What Makes Omnicell (OMCL) a New Strong Buy Stock

Omnicell (OMCL) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

1 month ago · zacks.com

Best Momentum Stocks to Buy for December 12th

ZIM, OMCL and FOA made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on December 12, 2024.

1 month ago · zacks.com

Omnicell Introduces OmniSphere Platform, Stock to Gain

Omnicell introduces OmniSphere. Additionally, the company showcases a full portfolio of outcomes-centric solutions at the ASHP Midyear 2024.

1 month ago · zacks.com

New Strong Buy Stocks for December 12th

NBBK, OMCL, ZIM, IMCR and ULS have been added to the Zacks Rank #1 (Strong Buy) List on December 12, 2024.

1 month ago · businesswire.com

Omnicell Announces OmniSphere

FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell Announces OmniSphere; Next-generation, cloud native, software workflow engine will integrate Omnicell solutions across care settings.

1 month ago · zacks.com

5 Medical Info System Stocks to Buy for a Stable Portfolio in 2025

Five medical info systems stocks have strong potential for 2025. These are: INSP, OMCL, TALK, BFLY, CLOV.

1 month ago · zacks.com

Why Is Omnicell (OMCL) Down 0.4% Since Last Earnings Report?

Omnicell (OMCL) reported earnings 30 days ago. What's next for the stock?

1 month ago · businesswire.com

Omnicell to Present at the Piper Sandler 36th Annual Healthcare Conference

FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell to Present at the Piper Sandler 36th Annual Healthcare Conference.

1 month ago · zacks.com

Wall Street Analysts Believe Omnicell (OMCL) Could Rally 26.73%: Here's is How to Trade

The mean of analysts' price targets for Omnicell (OMCL) points to a 26.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analyst...

1 month ago · businesswire.com

Omnicell Announces Pricing of $150 Million Convertible Senior Notes Offering

FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell Announces Pricing of $150 Million Convertible Senior Notes Offering.

1 month ago · businesswire.com

Omnicell Announces Proposed Private Placement of $150 Million of Convertible Senior Notes

FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell Announces Proposed Private Placement of $150 Million of Convertible Senior Notes.

1 month ago · zacks.com

Here's Why You Should Add OMCL Stock to Your Portfolio Now

A robust Advanced Services portfolio and long-term growth initiatives bode well for Omnicell.

2 months ago · zacks.com

Surging Earnings Estimates Signal Upside for Omnicell (OMCL) Stock

Omnicell (OMCL) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

2 months ago · seekingalpha.com

Omnicell Q3 Earnings: Look At The Growth Segment

Omnicell, Inc. is a pharmacy management provider working towards the goal of an autonomous pharmacy. Q3 earnings looked weak on the surface with revenue and EBITDA down, but results by business show a...

Load More News